Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Long-Term Investments (2019 - 2025)

Cellectis (CLLS) has 3 years of Long-Term Investments data on record, last reported at $8.1 million in Q4 2022.

  • For Q4 2022, Long-Term Investments rose 35.0% year-over-year to $8.1 million; the TTM value through Dec 2022 reached $8.1 million, up 35.0%, while the annual FY2022 figure was $8.1 million, 35.0% up from the prior year.
  • Long-Term Investments reached $8.1 million in Q4 2022 per CLLS's latest filing, up from $6.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $8.1 million in Q4 2022 and bottomed at $6.0 million in Q4 2020.
  • Average Long-Term Investments over 3 years is $6.7 million, with a median of $6.0 million recorded in 2020.
  • Peak YoY movement for Long-Term Investments: changed 0.0% in 2021, then soared 35.0% in 2022.
  • A 3-year view of Long-Term Investments shows it stood at $6.0 million in 2020, then changed by 0.0% to $6.0 million in 2021, then surged by 35.0% to $8.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $8.1 million in Q4 2022, $6.0 million in Q4 2021, and $6.0 million in Q4 2020.